Prevalence of extended-spectrum beta-lactamase-producing Enterobacteriaceae in healthy Swedish preschool children

Acta Paediatrica, International Journal of Paediatrics

Volumn 102, Issue 6, 2013, Pages 655-660

  Kaarme, Johan ^a   Molin, Ylva ^a   Olsen, Björn ^a   Melhus, Åsa ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Diaper; Extended spectrum beta lactamase; Faecal carriage; Preschool children

Indexed keywords

AMOXICILLIN; BETA LACTAMASE AMPC; CEFADROXIL; CEFTIBUTEN; CLAVULANIC ACID; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE;

ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATION; CHILD; DIAPER; ENTEROBACTERIACEAE; ESCHERICHIA COLI; FAMILIAL DISEASE; FECES ANALYSIS; GENOTYPE; GROUPS BY AGE; HUMAN; NONHUMAN; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; SWEDEN; TRANSMISSION ELECTRON MICROSCOPY;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CHILD; CHILD, PRESCHOOL; ENTEROBACTERIACEAE; ESCHERICHIA COLI INFECTIONS; FECES; FEMALE; HUMANS; INFANT; MALE; PREVALENCE; PROSPECTIVE STUDIES; SWEDEN;

EID: 84877576009     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/apa.12206     Document Type: Article

References (28)

1. Livermore DM,. Defining an extended-spectrum beta-lactamase. Clin Microbiol Infect 2008; 14 (Suppl 1): 3-10.
2. Knothe H, Shah P, Krcmery V, Antal M, Mitsuhashi S,. Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection 1983; 11: 315-7.
3. Paterson DL, Bonomo RA,. Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev 2005; 18: 657-86.
4. Pitout JDD,. Infections with extended-spectrum beta-lactamase-producing enterobacteriaceae: changing epidemiology and drug treatment choices. Drugs 2010; 70: 313-33.
5. Schwaber MJ, Carmeli Y,. Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis. J Antimicrob Chemother 2007; 60: 913-20.
6. Kim YK, Pai H, Lee HJ, Park SE, Choi EH, Kim J, et al. Bloodstream infections by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: epidemiology and clinical outcome. Antimicrob Agents Chemother 2002; 46: 1481-91.
7. Raymond J, Nordmann P, Doit C, VuThien H, Guibert M, Ferroni A, et al. Multidrug-resistant bacteria in hospitalized children: a 5-year multicenter study. Pediatrics 2007; 119: e 798-803.
8. Blaschke AJ, Korgenski EK, Daly JA, LaFleur B, Pavia AT, Byington CL,. Extended-spectrum beta-lactamase-producing pathogens in a children's hospital: a 5-year experience. Am J Infect Control 2009; 37: 435-41.
9. Janvier F, Mérens A, Delaune D, Soler C, Cavallo JD,. Fecal carriage of third generation cephalosporins resistant Enterobacteriaceae in asymptomatic young adults: evolution between 1999 and 2009. Pathol Biol (Paris) 2011; 59: 97-101.
10. Sasaki T, Hiari I, Niki M, Nakamura T, Komalamisra C, Maipanich W, et al. High prevalence of CTX-M beta-lactamase-producing Enterobacteriaceae in stool specimens obtained from healthy individuals in Thailand. J Antimicrob Chemother 2010; 65: 666-8.
11. Pallecchi L, Bartoloni A, Fiorelli C, Mantella A, Di Maggio T, Gamboa H, et al. Rapid dissemination and diversity of CTX-M extended-spectrum beta-lactamase genes in commensal Escherichia coli isolates from healthy children from low-resource settings in Latin America. Antimicrob Agents Chemother 2007; 51: 2720-5.
12. Guimarães B, Barreto A, Radhouani H, Figueiredo N, Gaspar E, Rodrigues J, et al. Genetic detection of extended-spectrum beta-lactamase- containing Escherichia coli isolates and vancomycin-resistant enterococci in fecal samples of healthy children. Microb Drug Resist 2009; 15: 211-6.
13. Nielsen JB, Skov MN, Jørgensen RL, Heltberg O, Hansen DS, Schønning K,. Identification of CTX-M-15-, SHV-28-producing Klebsiella pneumoniae ST15 as an epidemic clone in the Copenhagen area using a semi-automated Rep-PCR typing assay. Eur J Clin Microbiol Infect Dis 2011; 30: 773-8.
14. Lytsy B, Sandegren L, Tano E, Torell E, Andersson DI, Melhus A,. The first major extended-spectrum beta-lactamase outbreak in Scandinavia was caused by clonal spread of a multiresistant Klebsiella pneumoniae producing CTX-M-15. APMIS 2008; 116: 302-8.
15. Murray PR, Baron EJ, Jorgensen JH, Landry ML, Pfaller MA,. Manual of clinical microbiology, 9th ed. Washington DC: ASM Press, 2007.
16. Carter MW, Oakton KJ, Warner M, Livermore DM,. Detection of extended-spectrum beta lactamases in klebsiellae with the Oxoid combination disk method. J Clin Microbiol 2000; 38: 4228-32.
17. Coudron PE,. Inhibitor-based methods for detection of plasmid-mediated AmpC beta-lactamases in Klebsiella spp., Escherichia coli, and Proteus mirabilis. J Clin Microbiol 2005; 43: 4163-7.
18. Pitout JD, Hossain A, Hanson ND,. Phenotypic and molecular detection of CTX-M-beta-lactamases produced by E. coli and Klebsiella spp. J Clin Microbiol 2004; 42: 5712-21.
19. Pérez-Pérez FJ, Hanson ND,. Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol 2002; 40: 2153-62.
20. van Belkum A, Tassios PT, Dijkshoorn L, Haeggman S, Cookson B, Fry NK, et al. Guidelines for the validation and application of typing methods for use in bacterial epidemiology. Clin Microbiol Infect 2007; 13 (Suppl 3): 1-46.
21. Lo WU, Ho PL, Chow KH, Lai EL, Yeung F, Chiu SS,. Fecal carriage of CTXM type extended-spectrum beta-lactamase-producing organisms by children and their household contacts. J Infect 2010; 60: 286-92.
22. Doi Y, Paterson DL, Egea P, Pascual A, Lõpez-Cerero L, Navarro MD, et al. Extended-spectrum and CMY-type beta-lactamase-producing Escherichia coli in clinical samples and retail meat from Pittsburgh, USA and Seville, Spain. Clin Microbiol Infect 2010; 16: 33-8.
23. Ewers C, Bethe A, Semmler T, Guenther S, Wieler LH,. Extended-spectrum β-lactamase-producing and AmpC-producing Escherichia coli from livestock and companion animals, and their putative impact on public health: a global perspective. Clin Microbiol Infect 2012; 18: 646-55.
24. Dubois V, De Barbeyrac B, Rogues AM, Arpin C, Coulange L, Andre C, et al. CTX-M-producing Escherichia coli in a maternity ward: a likely community importation and evidence of mother-to-neonate transmission. J Antimicrob Chemother 2010; 65: 1368-71.
25. Rodríguez-Baño J, Alcalá JC, Cisneros JM, Grill F, Oliver A, Horcajada JP, et al. Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. Arch Intern Med 2008; 168: 1897-902.
26. Tängdén T, Cars O, Melhus Å, Löwdin E,. Foreign travel is a major risk factor for colonization with Escherichia coli producing CTX-M-type extended-spectrum beta-lactamases: a prospective study with Swedish volunteers. Antimicrob Agents Chemother 2010; 54: 3564-8.
27. Tamma PD, Savard P, Pál T, Sonnevend A, Perl TM, Milstone AM,. An outbreak of extended-spectrum β-lactamase-producing Klebsiella pneumoniae in a neonatal intensive care unit. Infect Control Hosp Epiedmiol 2012; 33: 631-4.
28. Kola A, Holst M, Chaberny IF, Ziesing S, Suerbaum S, Gastmeier P,. Surveillance of extended-spectrum beta-lactamase-producing bacteria and routine use of contact isolation: experience from a three-year period. J Hosp Infect 2007; 66: 46-51.